Startup company ViralClear Pharmaceuticals’ broad-spectrum antiviral drug merimepodib is about to enter Phase II studies for COVID-19.
Roche and Gilead Sciences launched a Phase III clinical trial in severe COVID-19 pneumonia, testing Roche’s Actemra/RoActemra with Gilead’s remdesivir.
A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body.
The novel coronavirus has killed more than 100,000 people in the United States, according to a Reuters tally, even as the slowdown in deaths encouraged businesses to reopen and Americans to emerge from more than two months of lockdowns.
France, Italy and Belgium acted to halt the use of hydroxychloroquine to treat patients suffering from COVID-19 amid questions about the safety of the generic anti-malaria drug.
A French consortium is stepping up previously announced plans for a saliva-based screening test to detect COVID-19, by joining up with medical laboratory and diagnostics group INOVIE.
Questions over the efficacy and safety of hydroxychloroquine continue to be raised following the World Health Organization’s decision to temporarily halt a study of the malaria drug as a potential treatment for COVID-19.
Merck exploded into the COVID-19 battle with three significant deals and collaborations.
Siemens Healthineers stands ready to ramp up production of the company’s antibody test to more than 50 million per month from June 2020 as governments across the world are keen to identify those who may have developed immunity to the coronavirus.
A group of tech companies is working on a patch about the size of a small bandage that could be worn to monitor for the elevated body temperatures that can sometimes signal the onset of COVID-19.